Aqualung Therapeutics' Scientific Advisory Board (SAB) is composed of distinguished experts in pulmonary medicine, immunology, and drug development. This group provides strategic scientific guidance, evaluates our research approach, and ensures our programs align with the latest advancements in the field. Their insights help accelerate the development of our biologic therapies and reinforce our commitment to scientific excellence.
Learn more about our advisors below.
William L Macias, MD, PhD
Robert Schleimer, PhD
Jesse Hall, MD
Edwin M Posadas, MD
Ralph Weichselbaum, MD
-
Chief Medical Officer
Immunovant
-
Roy and Elaine Patterson Professor of Medicine Professor of Medicine (Allergy and Immunology), Microbiology-Immunology and Otolaryngology - Head and Neck Surgery
Northwestern University School of Medicine
-
Professor Emeritus of Medicine and Anesthesia & Critical Care
University of Chicago
-
Medical Director, Urologic Oncology Program Co-Director, Experimental Therapeutics Program Associate Professor, Medicine
Cedars Sinai
-
Daniel K. Ludwig Distinguished Service Professor of Radiation and Cellular Oncology Chair, Department of Radiation and Cellular Oncology
UChicago Medicine